Physician

Hannah D Yamin, DO

According to 2025 Medicare claims, Hannah Yamin, DO (NPI: 1841476934) practices hematology/oncology in the Barnstable Town, MA market, with the plurality of this provider's patient population coming from Barnstable, MA. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1003677014; TIN: 223141761) and primary practice location at 02556-2820.

Yamin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 632 traditional Medicare patients, billed 194,412 HCPCS/CPT codes, and received $2,767,511 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 757 prescription claims across 137 beneficiaries totaling $2,992,599 in drug costs, led by Ibrance (Palbociclib). 2019 DME data shows 11 claims. Open Payments data shows 1 records totaling $18. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $982,645 to $2,767,511. Similarly, Part D prescription costs have moved sharply higher in recent years, from $239,129 to $2,992,599. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	533	90,314	$982,645
2016	535	89,521	$1,112,065
2017	513	76,173	$1,190,784
2018	485	83,581	$1,043,314
2019	528	105,945	$1,562,032
2020	425	118,592	$1,713,006
2021	544	170,836	$2,475,930
2022	585	216,947	$3,703,030
2023	567	162,187	$2,608,370
2024	632	194,412	$2,767,511

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	332	$239,129
2016	78	456	$645,811
2017	103	623	$872,879
2018	106	664	$900,820
2019	106	621	$1,184,185
2020	114	700	$2,010,788
2021	134	671	$1,966,916
2022	136	737	$2,811,513
2023	148	727	$3,063,460
2024	137	757	$2,992,599

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	54	$3,774
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$1,988
2019	N/R	11	$627
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	263	592	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	356	671	$74
96372	Injection of drug or substance under skin or into muscle	111	559	$12
36415	Insertion of needle into vein for collection of blood sample	249	885	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	307	1,202	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	38	1,064	$603,647
Lenalidomide	Lenalidomide	40	1,120	$595,712
Imbruvica	Ibrutinib	36	1,008	$579,520
Revlimid	Lenalidomide	33	924	$528,174
Calquence	Acalabrutinib Maleate	12	360	$151,978

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$18	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hannah D. Yamin, DO?

Tedicare shows public-source Medicare data for Hannah D. Yamin, DO (NPI 1841476934), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hannah D. Yamin, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hannah D. Yamin, DO?

Hannah D. Yamin, DO is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1003677014) in the available physician profile data.

Does Hannah D. Yamin, DO have Open Payments data?

Hannah D. Yamin, DO has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.